<DOC>
	<DOCNO>NCT00001166</DOCNO>
	<brief_summary>Gyrate atrophy rare hereditary disease eye 's retina ( layer light-sensitive tissue line inside eyeball ) choroid ( vascular layer tissue behind retina ) . Degeneration structure cause near-sightedness , cataract progressive loss vision . This study examine eye function chemical molecular abnormality patient gyrate atrophy try good understand , diagnose , treat condition . Patients degenerative disease choroid retina , retinitis pigmentosa , choroideremia , others , also study comparison . Family member patient study , possible , try identify genetic basis disease gain information aid genetic counseling . Study participant undergo physical examination eye examination , include test color vision , field vision , ability see dark . An electroretinogram electrooculogram measure visual cell function . Photographs retina take . Blood drawn biochemical study gene research . Family member agree participate study undergo eye test also blood draw genetic study . Patients gyrate atrophy also ask undergo small skin biopsy biochemical genetic study . They provide family history order draw family tree show disease distribute among family member . Patients gyrate atrophy may also participate study effect vitamin B6 diet blood level amino acid ornithine , elevate patient gyrate atrophy . Participants take 500 mg vitamin B6 mouth every day 3 6 month . If study confirm reduction ornithine level , long-term study vitamin possible treatment disease may start . After vitamin B6 study , patient start nearly protein-free diet low ornithine blood level . More 2,000 calorie carbohydrate fat . Some special low-protein food limit fruit include , plus amino acid supplement . Patients carefully adhere diet lowered ornithine level slow disease progression . Patients hospitalize first 1 3 week close monitor frequent urine blood test . When blood ornithine level normalize , less restrict low protein diet prescribe . Participants monthly blood test complete eye examination every 6 month 1 year evaluate disease progression .</brief_summary>
	<brief_title>Gyrate Atrophy Choroid Retina</brief_title>
	<detailed_description>Gyrate atrophy choroid retina ( GA ) rare autosomal recessive chorioretinal degeneration characterize myopia , cataract , vary degree night blindness , progressive constriction visual field associate chorioretinal atrophy result blindness . The objective protocol threefold : 1 . Document natural history gyrate atrophy . 2 . Relate clinical course gene defect explore genetic heterogeneity inherent disease . 3 . Assess clinical course laboratory finding effect arginine-deficient diet . The study population patient elevate plasma ornithine absence ornithine-delta-aminotransferase activity . This natural history study , nest intervention study , non-randomized , outcome parameter psychophysical , electrophysiological ophthalmoscopic examination .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Gyrate Atrophy</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients must hyperornithemia deficiency OAT activity enter study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>Hyperornithinemia</keyword>
	<keyword>Ornithine-Aminotransferase ( OAT )</keyword>
	<keyword>Tissue Culture</keyword>
	<keyword>Pyridoxine Hydrochloride</keyword>
	<keyword>Pyridoxal Phosphate</keyword>
	<keyword>Arginine</keyword>
	<keyword>Skin Fibroblast</keyword>
	<keyword>Gyrate Atrophy</keyword>
	<keyword>Autosomal Recessive Retinitis Pigmentosa</keyword>
	<keyword>Bietti 's Crystalline Retinopathy</keyword>
	<keyword>Chorioretinal Degeneration</keyword>
</DOC>